this los angeles times article on a new treatment for sma type this is very promising news and i believe it will lead to additional breakthroughs for type , and sma is different then sbma kennedy 's disease , but antisense technology is being used in other progressive disorders and could be the bridge to a treatment below is an excerpt from the times article you can read the entire article by following this link ionis shares leap after a drug trial goes so well , it ends early the only option spinal muscular atrophy occurs in about out of , to , births it 's caused by mutations in a gene that reduce production of a protein needed for survival of movement controlling spinal neurons nusinersen increases production of the protein from a closely related gene by altering how rna made from the gene is translated into protein this is done with antisense technology , a field pioneered by ionis drugs based on antisense technology are meant to block or change how targeted genetic instructions delivered through rna affect the making of proteins , which are the building blocks of life for instance , they could block certain mutations from resulting in protein synthesis that causes an unwanted medical condition nusinersen has been granted orphan drug status in both the u s and the european union indicating it shows promise in treating a rare disease or condition and it s designated for fast track review in the united states image http www slideshare net pooranachithraflowry antisense therapy